News

Newsletter

Brazilian Senate rejects the postponement of the LGPD

It has been two years since the Brazilian General Data Protection Law (LGPD) was enacted. Such law will enable greater control by Brazilians over their personal data, as well as have considerable impact over individuals’ and companies’ routines. Therefore, the correct date of its entry into force is a relevant issue.
 
Last Wednesday (26) a controversy in the Brazilian Congress, between the Senate and the House of Representatives, caused the anticipation of the date in which the LDPD would enter into force, which was supposed to be December 2020.  
 
For further information, click below to access our full newsletter.
Back

Last related news

September 6, 2022

Brazilian National Health Surveillance Agency authorizes exceptional drug and vaccine use against Monkeypox by the Ministry of Health

The Ministry of Health (MH) sent Brazilian National Health Surveillance Agency (Anvisa) a request for exemption from the sanitary registration, on an Brazilian National Health Surveillance Agency authorizes exceptional drug and vaccine use against Monkeypox by the Ministry of Health

Ler notícia

August 16, 2022

Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

On August 8th, 2022, during the 12th Extraordinary Public Meeting of DICOL, ANVISA’s Collegiate Board of Directors announced the completion of the toxicological Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

Ler notícia

July 19, 2022

Carbendazim toxicological revaluation about to be completed by ANVISA

In December 2019, ANVISA started the process of toxicological revaluation of the Active Ingredient (AI) Carbendazim, as signs of toxicity were identified Carbendazim toxicological revaluation about to be completed by ANVISA

Ler notícia